Russell Investments Group, Ltd.

Position in ALXO — Alx Oncology Holdings Inc

CIK 1692234 Seattle, WA

Position in ALXO

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$17,859

+$17,479 QoQ

Shares Held

8,628

+3684.2% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#84

of 94 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. ALXO ranks #265 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,859	8,628	+3684.2%	Shares	Defined	2026-08-06
2024-12-31	$380	228	+132.7%	Shares	Defined	2025-02-13
2024-09-30	$178	98	-95.8%	Shares	Defined	2024-11-13
2024-06-30	$14,055	2,331	+766.5%	Shares	Defined	2024-08-08
2023-06-30	$2,020	269	-99.3%	Shares	Defined	2023-08-10
2022-12-31	$459,962	40,813	0.0%	Shares	Defined	2023-02-08
2022-09-30	$390,580	40,813	-48.7%	Shares	Defined	2022-11-04
2022-06-30	$643,858	79,587	+30.5%	Shares	Defined	2022-07-29
2022-03-31	$1,030,898	61,000	+47.2%	Shares	Defined	2022-05-05
2021-12-31	$890,329	41,430	+36.6%	Shares	Defined	2022-01-21
2021-09-30	$2,240,246	30,331	0.0%	Shares	Defined	2021-11-08
2021-06-30	$1,658,497	30,331	—	Shares	Defined	2021-08-04
No filing history on record for this holder in this stock.